Eterna Therapeutics
Stock Forecast, Prediction & Price Target

Eterna Therapeutics Financial Estimates

Eterna Therapeutics Revenue Estimates

Eterna Therapeutics EBITDA Estimates

Eterna Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$68K
 
0%
Avg: $32.81M
Low: $32.81M
High: $32.81M
avg. 48152.93%
Avg: $75.34M
Low: $75.34M
High: $75.34M
avg. 129.62%
Net Income
 
% change YoY
$-122.30M
 
N/A
$-24.57M
 
79.90%
$-21.66M
 
11.84%
Avg: $-57.39M
Low: $-57.39M
High: $-57.39M
avg. -164.86%
Avg: $-62.70M
Low: $-62.70M
High: $-62.70M
avg. -9.25%
EBITDA
 
% change YoY
$68.80M
 
N/A
$-32.03M
 
-146.55%
$-19.93M
 
37.76%
Avg: $13.77M
Low: $13.77M
High: $13.77M
avg. 169.09%
Avg: $31.62M
Low: $31.62M
High: $31.62M
avg. 129.62%
EPS
 
% change YoY
-$56.49
 
N/A
-$8.06
 
85.73%
-$4.08
 
49.37%
Avg: -$10.8
Low: -$10.8
High: -$10.8
avg. -164.70%
Avg: -$11.8
Low: -$11.8
High: -$11.8
avg. -9.25%
Operating Expenses
 
% change YoY
$27.42M
 
N/A
$27.22M
 
-0.73%
$20.73M
 
-23.85%
Avg: $1.32B
Low: $1.32B
High: $1.32B
avg. 6283.20%
Avg: $3.03B
Low: $3.03B
High: $3.03B
avg. 129.62%

FAQ

What is Eterna Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of -87.06% in 2025-2026.

We have gathered data from N/A analysts. Their low estimate is -57.39M, average is -57.39M and high is -57.39M.

What is Eterna Therapeutics stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 24141.28% in 2025-2026.

We have gathered data from 1 analysts. Their low revenue estimate is $32.81M, average is $32.81M and high is $32.81M.

What is Eterna Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of -86.98% in 2025-2026.

We have gathered data from N/A analysts. Their low earnings per share estimate is -$10.8, average is -$10.8 and high is $-10.8.